Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials. 18. Februar 2022 Dechow T, Aldaoud A, Behlendorf T, Knauf W, Eschenburg H, Groschek M, Hansen R, Söling U, Grebhardt S, Siebenbach HU, Vannier C, Potthoff K, 2022. European Journal of Haematology, Volume 108, Issue 2, p. 133-144, 2022. https://doi.org/10.1111/ejh.13719 Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3). Moehler M, Folprecht G, Heinemann V, Holch JW, Maderer A, Kasper S, Hegewisch-Becker S, Schröder J, Overkamp F, Kullmann F, Bechstein WO, Vöhringer M, Öllinger… Weiterlesen Sequential treatment patterns over time for advanced renal cell carcinoma – Data from the German research platform CARAT. Goebell, P.J., Grüllich, C., Müller, L., Bögemann, M., Martens, U., von der Heyde, E., Reichert, D., Nusch, A., Schlenska-Lange., A., Wetzel, N., Koska, M., Jänicke,… Weiterlesen